Samuele Cortese, MD: COVID-19 Offers Opportunity for ADHD Patients


Dr. Cortese explains how more data could improve ADHD care.

The ongoing coronavirus disease 2019 (COVID-19) pandemic might change exactly how attention deficit/hyperactivity disorder (ADHD) is treated.

With many students forced to go to school over the computer and workers across the globe forced to work from home there undoubtedly will be some challenges and struggles for this patient population.

In an interview with HCPLive®, Samuele Cortese, MD, PhD, Professor of Child and Adolescent Psychiatry, University of Southampton, explained what he thinks will be some issues moving forward for ADHD patients and how doctors can handle some of the challenges linked to the pandemic.

Cortese said the pandemic has strengthened the idea there is a patient’s quality of life could substantially improve if ADHD is treated correctly. He said the cognitive symptoms must be first and foremost in crafting an individual treatment plan and by doing so doctors can improve the other aspects of the patient’s life.

One bright spot of the pandemic, Cortese said, is that there will be more data available on what ADHD patients are facing and struggling with.

Recent Videos
Boadie Dunlop, MD, Weighs in on FDA Advisory Vote on Lykos’ MDMA
Bhanu Prakash Kolla, MBBS, MD: Treating Sleep with Psychiatric Illness
Awaiting FDA Decision on MDMA Assisted Therapy, with Bessel van der Kolk, MD
Bessel van der Kolk, MD: The Future of MDMA Assisted Therapy in PTSD
Bessel van der Kolk, MD: What MDMA-Assisted Therapy Taught us About PTSD
Why Are Adult ADHD Cases Climbing?
Aaron Henry, PA-C, MSHS: Regaining Black Male Patient Trust in the Doctor's Office
Depression Screening: Challenges and Solutions at the Primary Care Level
Danielle O'Laughlin, PA-C, MS: Navigating Long-Term Risks, Family Planning in PCOS
HCPLive Five at APA 2024 | Image Credit: HCPLive
© 2024 MJH Life Sciences

All rights reserved.